Results: 76-100/6233
Authors:
Pavillard, V
Kherfellah, D
Richard, S
Robert, J
Montaudon, D
Citation: V. Pavillard et al., Effects of the combination of camptothecin and doxorubicin or etoposide onrat glioma cells and camptothecin-resistant variants, BR J CANC, 85(7), 2001, pp. 1077-1083
Authors:
Gatta, G
Capocaccia, R
Berrino, F
Citation: G. Gatta et al., Cancer survival differences between European populations: the UK uneasiness, BR J CANC, 85(6), 2001, pp. 785-786
Authors:
Woodman, CBJ
Gibbs, A
Scott, N
Haboubi, NY
Collins, S
Citation: Cbj. Woodman et al., Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?, BR J CANC, 85(6), 2001, pp. 787-790
Authors:
Lantzsch, T
Wolters, M
Grimm, J
Mende, T
Buchmann, J
Sliutz, G
Koelbl, H
Citation: T. Lantzsch et al., Sentinel node procedure in Ib cervical cancer: a preliminary series, BR J CANC, 85(6), 2001, pp. 791-794
Authors:
Coradini, D
Boracchi, P
Daidone, MG
Pellizzaro, C
Miodini, P
Ammatuna, M
Tomasic, G
Biganzoli, E
Citation: D. Coradini et al., Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer, BR J CANC, 85(6), 2001, pp. 795-797
Authors:
Kalbakis, K
Kouroussis, C
Kakolyris, S
Mavroudis, D
Souglakos, J
Agelaki, S
Vamvakas, L
Christodoulakis, M
Stylianou, K
Georgoulias, V
Citation: K. Kalbakis et al., Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes, BR J CANC, 85(6), 2001, pp. 798-802
Authors:
Melia, J
Moss, S
Coleman, D
Frost, T
Graham-Brown, R
Hunter, JAA
Marsden, RA
du Vivier, A
Warin, AP
White, J
Whitehead, SM
Wroughton, MA
Citation: J. Melia et al., The relation between mortality from malignant melanoma and early detectionin the Cancer Research Campaign Mole Watcher Study, BR J CANC, 85(6), 2001, pp. 803-807
Authors:
Lebitasy, MP
Hedelin, G
Purohit, A
Moreau, L
Klinzig, F
Quoix, E
Citation: Mp. Lebitasy et al., Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994, BR J CANC, 85(6), 2001, pp. 808-815
Authors:
Ray-Coquard, I
Ghesquiere, H
Bachelot, T
Borg, C
Biron, P
Sebban, C
LeCesne, A
Chauvin, F
Blay, JY
Citation: I. Ray-coquard et al., Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas, BR J CANC, 85(6), 2001, pp. 816-822
Authors:
von Schlippe, M
Fowler, CJ
Harland, SJ
Citation: M. Von Schlippe et al., Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis, BR J CANC, 85(6), 2001, pp. 823-826
Authors:
Iacopetta, B
Grieu, F
Joseph, D
Elsaleh, H
Citation: B. Iacopetta et al., A polymorphism in the enhancer region of the thymidylate synthase promoterinfluences the survival of colorectal cancer patients treated with 5-fluorouracil, BR J CANC, 85(6), 2001, pp. 827-830
Authors:
Anderson, J
Gordon, T
McManus, A
Mapp, T
Gould, S
Kelsey, A
McDowell, H
Pinkerton, R
Shipley, J
Pritchard-Jones, K
Citation: J. Anderson et al., Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?, BR J CANC, 85(6), 2001, pp. 831-835
Authors:
Della Torre, G
Pasini, B
Frigerio, S
Donghi, R
Rovini, D
Delia, D
Peters, G
Huot, TJG
Bianchi-Scarra, G
Lantieri, F
Rodolfo, M
Parmiani, G
Pierotti, MA
Citation: G. Della Torre et al., CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation, BR J CANC, 85(6), 2001, pp. 836-844
Authors:
Casadei, S
Cortesi, L
Pensotti, V
Radice, P
Pierotti, M
Amadori, D
Calistri, D
Citation: S. Casadei et al., Detection of germline BRCA1 mutations by multiple-dye cleavase fragment length polymorphism (MD-CFLP) method, BR J CANC, 85(6), 2001, pp. 845-849
Authors:
Steinmann, D
Bremer, M
Rades, D
Skawran, B
Siebrands, C
Karstens, JH
Dork, T
Citation: D. Steinmann et al., Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer, BR J CANC, 85(6), 2001, pp. 850-858
Authors:
Bergman-Jungestrom, M
Wingren, S
Citation: M. Bergman-jungestrom et S. Wingren, Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women, BR J CANC, 85(6), 2001, pp. 859-862
Authors:
Edwards, JG
Cox, G
Andi, A
Jones, JL
Walker, RA
Waller, DA
O'Byrne, KJ
Citation: Jg. Edwards et al., Angiogenesis is an independent prognostic factor in malignant mesothelioma, BR J CANC, 85(6), 2001, pp. 863-868
Authors:
Warnberg, F
Nordgren, H
Bergkvist, L
Holmberg, L
Citation: F. Warnberg et al., Tumour markers in breast carcinoma correlate with grade rather than with invasiveness, BR J CANC, 85(6), 2001, pp. 869-874
Authors:
Czarnocka, B
Pastuszko, D
Janota-Bzowski, M
Weetman, AP
Watson, PF
Kemp, EH
McIntosh, RS
Asghar, MS
Jarzab, B
Gubala, E
Wioch, J
Lange, D
Citation: B. Czarnocka et al., Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?, BR J CANC, 85(6), 2001, pp. 875-880
Authors:
Giatromanolaki, A
Koukourakis, MI
Sivridis, E
Turley, H
Talks, K
Pezzella, F
Gatter, KC
Harris, AL
Citation: A. Giatromanolaki et al., Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival, BR J CANC, 85(6), 2001, pp. 881-890
Authors:
Scotton, C
Milliken, D
Wilson, J
Raju, S
Balkwill, F
Citation: C. Scotton et al., Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours, BR J CANC, 85(6), 2001, pp. 891-897
Authors:
Narayan, S
Jaiswal, AS
Multani, AS
Pathak, S
Citation: S. Narayan et al., DNA damage-induce cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2, BR J CANC, 85(6), 2001, pp. 898-901
Authors:
Galmarini, CM
Falette, N
Tabone, E
Levrat, C
Britten, R
Voorzanger-Rousselot, N
Roesch-Gateau, O
Vanier-Viornery, A
Puisieux, A
Dumontet, C
Citation: Cm. Galmarini et al., Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity, BR J CANC, 85(6), 2001, pp. 902-908
Authors:
Andronicos, NM
Ranson, M
Citation: Nm. Andronicos et M. Ranson, The topology of plasminogen binding and activation on the surface of humanbreast cancer cells, BR J CANC, 85(6), 2001, pp. 909-916
Authors:
Di Benedetto, M
Kourbali, Y
Starzec, A
Vassy, R
Jozefonvicz, J
Perret, G
Crepin, M
Kraemer, M
Citation: M. Di Benedetto et al., Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice, BR J CANC, 85(6), 2001, pp. 917-923